MOG 94 - 110, human

MOG 94 - 110, human
€170.00 *

Prices plus VAT plus shipping costs

Delivery time 3 weeks
sterile and endotoxin free Delivery Format:
The product is supplied freeze dried as trifluoracetate salt

Amount in mg:

make your choice

  • EP09881_1
Myelin oligodendrocyte glycoprotein (MOG)94 - 110, a minor component of CNS myelin, is expressed... more
Product information "MOG 94 - 110, human"
Myelin oligodendrocyte glycoprotein (MOG)94 - 110, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is believed to be a target autoantigen in multiple sclerosis. MOG 94 - 110 peptide is an immunodominant epitope of MOG that induces strong T and B cell responses and Induces experimental autoimmune encephalomyelitis in rodents. A single injection of this peptide produces a relapsing-remitting neurologic disease with extensive plaque-like demyelination. This Cysteine containing MOG 94 - 110 peptide can be use to induced polyclonal anti-MOG 94 - 110 antibody production in rabbits with high specificity, high affinity, and high titer indicating its high purity, as well as suitability for peptide-coated ELISA and Western blot assay. Immunization with MOG 94 - 110 suppresses spontaneous regeneration of dopaminergic neurons injured with MPTP. Multiple Sclerosis: MOG 94 - 110 induced experimental autoimmune encephalomyelitis (EAE) rodent modelsMyelin oligodendrocyte glycoprotein (MOG)94 - 110, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is believed to be a target autoantigen in multiple sclerosis. MOG 94 - 110 peptide is an immunodominant epitope of MOG that induces strong T and B cell responses and Induces experimental autoimmune encephalomyelitis in rodents. A single injection of this peptide produces a relapsing-remitting neurologic disease with extensive plaque-like demyelination. This Cysteine containing MOG 94 - 110 peptide can be use to induced polyclonal anti-MOG 94 - 110 antibody production in rabbits with high specificity, high affinity, and high titer indicating its high purity, as well as suitability for peptide-coated ELISA and Western blot assay. Immunization with MOG 94 - 110 suppresses spontaneous regeneration of dopaminergic neurons injured with MPTP. Multiple Sclerosis: MOG 94 - 110 induced experimental autoimmune encephalomyelitis (EAE) rodent modelsMyelin oligodendrocyte glycoprotein (MOG)94 - 110, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is believed to be a target autoantigen in multiple sclerosis. MOG 94 - 110 peptide is an immunodominant epitope of MOG that induces strong T and B cell responses and Induces experimental autoimmune encephalomyelitis in rodents. A single injection of this peptide produces a relapsing-remitting neurologic disease with extensive plaque-like demyelination. This Cysteine containing MOG 94 - 110 peptide can be use to induced polyclonal anti-MOG 94 - 110 antibody production in rabbits with high specificity, high affinity, and high titer indicating its high purity, as well as suitability for peptide-coated ELISA and Western blot assay. Immunization with MOG 94 - 110 suppresses spontaneous regeneration of dopaminergic neurons injured with MPTP. Multiple Sclerosis: MOG 94 - 110 induced experimental autoimmune encephalomyelitis (EAE) rodent modelsMyelin oligodendrocyte glycoprotein (MOG)94 - 110, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is believed to be a target autoantigen in multiple sclerosis. MOG 94 - 110 peptide is an immunodominant epitope of MOG that induces strong T and B cell responses and Induces experimental autoimmune encephalomyelitis in rodents. A single injection of this peptide produces a relapsing-remitting neurologic disease with extensive plaque-like demyelination. This Cysteine containing MOG 94 - 110 peptide can be use to induced polyclonal anti-MOG 94 - 110 antibody production in rabbits with high specificity, high affinity, and high titer indicating its high purity, as well as suitability for peptide-coated ELISA and Western blot assay. Immunization with MOG 94 - 110 suppresses spontaneous regeneration of dopaminergic neurons injured with MPTP. Multiple Sclerosis: MOG 94 - 110 induced experimental autoimmune encephalomyelitis (EAE) rodent modelsMyelin oligodendrocyte glycoprotein (MOG)94 - 110, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is believed to be a target autoantigen in multiple sclerosis. MOG 94 - 110 peptide is an immunodominant epitope of MOG that induces strong T and B cell responses and Induces experimental autoimmune encephalomyelitis in rodents. A single injection of this peptide produces a relapsing-remitting neurologic disease with extensive plaque-like demyelination. This Cysteine containing MOG 94 - 110 peptide can be use to induced polyclonal anti-MOG 94 - 110 antibody production in rabbits with high specificity, high affinity, and high titer indicating its high purity, as well as suitability for peptide-coated ELISA and Western blot assay. Immunization with MOG 94 - 110 suppresses spontaneous regeneration of dopaminergic neurons injured with MPTP. Multiple Sclerosis: MOG 94 - 110 induced experimental autoimmune encephalomyelitis (EAE) rodent modelsMyelin oligodendrocyte glycoprotein (MOG)94 - 110, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is believed to be a target autoantigen in multiple sclerosis. MOG 94 - 110 peptide is an immunodominant epitope of MOG that induces strong T and B cell responses and Induces experimental autoimmune encephalomyelitis in rodents. A single injection of this peptide produces a relapsing-remitting neurologic disease with extensive plaque-like demyelination. This Cysteine containing MOG 94 - 110 peptide can be use to induced polyclonal anti-MOG 94 - 110 antibody production in rabbits with high specificity, high affinity, and high titer indicating its high purity, as well as suitability for peptide-coated ELISA and Western blot assay. Immunization with MOG 94 - 110 suppresses spontaneous regeneration of dopaminergic neurons injured with MPTP. Multiple Sclerosis: MOG 94 - 110 induced experimental autoimmune encephalomyelitis (EAE) rodent modelsMyelin oligodendrocyte glycoprotein (MOG)94 - 110, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is believed to be a target autoantigen in multiple sclerosis. MOG 94 - 110 peptide is an immunodominant epitope of MOG that induces strong T and B cell responses and Induces experimental autoimmune encephalomyelitis in rodents. A single injection of this peptide produces a relapsing-remitting neurologic disease with extensive plaque-like demyelination. This Cysteine containing MOG 94 - 110 peptide can be use to induced polyclonal anti-MOG 94 - 110 antibody production in rabbits with high specificity, high affinity, and high titer indicating its high purity, as well as suitability for peptide-coated ELISA and Western blot assay. Immunization with MOG 94 - 110 suppresses spontaneous regeneration of dopaminergic neurons injured with MPTP. Multiple Sclerosis: MOG 94 - 110 induced experimental autoimmune encephalomyelitis (EAE) rodent models

 
Sequence:GFTCFFRDHSYQEEAAM
Gene:mog
Delivery: 3 weeks
C-Terminus:OH
N-Terminus:H
Purity:95%
Amount:1 mg
Counter Ion:TFA
Protein:Myelin oligodendrocyte glycoprotein
Species:Human
Application :Multiple Sclerosis
IE62 (HLA-A*02:01) IE62 (HLA-A*02:01)
From €50.00 *
MUC1 (HLA-B*07:02) MUC1 (HLA-B*07:02)
From €50.00 *
Viewed